Deschamps Philippe 4

What Happened
Philippe Deschamps, a director of Coeptis Therapeutics Holdings, exercised stock options and acquired shares on Feb 11, 2026. He exercised options to acquire 5,700 shares at an exercise price of $10.56 per share (total cash paid $60,192) and was also granted 3,250 restricted shares (no cash paid) as part of an option-exchange award.

Key Details

• Transaction date: 2026-02-11 (Form 4 filed 2026-02-13).
• Option exercise: 5,700 shares acquired at $10.56 per share (represents the exercise price) — total $60,192.
• Grant/award: 3,250 restricted shares issued at $0.00 (exchange grant).
• Footnotes: F1 = exercise price shown; F2 = restricted stock granted in exchange for surrendering underwater options.
• Shares owned after transaction: Not specified in the filing.

Context
This was an acquisition event (exercise and grant), not a sale. The restricted stock was issued under an option-exchange program where underwater options were surrendered in return for restricted shares; the exercised options required cash payment equal to the exercise price. Such filings are routine disclosures of insider acquisitions and do not, by themselves, indicate the director's future trading intentions.